Home
Soleus Capital Master Fund reported a 7.6% stake in Context Therapeutics CNTX · 6,963,141 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.6%
- Last report
- 5.2% · filed 26/02/03
- Shares held
- 6,963,141 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/03/31
- Filed
- 26/05/08
7.6% stake · +2.4pp from the last report
- Stake
- 7.6%
- Last report
- 5.2%
- Since last report
- +2.4pp
Context Therapeutics trades, last 26 weeks
What else happened in Context Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Soleus Capital Master Fund's other 5% stake reports
- Soleus Capital Master Fund
5% stakeEvolus
5% stakeEvolus
EOLS
5.3% stake
3,480,000 sh
5.3% stake
Filed 08/31
- Soleus Capital Master Fund
5% stakeProcessa Pharmaceuticals
5% stakeProcessa Pharmaceuticals
PCSA
5.8% stake
160,943 sh
5.8% stake
Filed 08/18
- Soleus Capital Master Fund
5% stakeInspire Medical Systems
5% stakeInspire Medical Systems
INSP
6.7% stake
1,931,436 sh
6.7% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakePalisade Bio
5% stakePalisade Bio
PALI
7.5% stake
13,063,687 sh
7.5% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakeRigel Pharmaceuticals
5% stakeRigel Pharmaceuticals
RIGL
9.9% stake
1,843,504 sh
9.9% stake
Filed 08/13
